1286
E. Kh. Ahmed – M. A. Ameen · Tethering Monosaccharides to Thieno[2,3-d]pyrimidinones
3-(2-Ethoxy-2-oxoethyl)-2-thioxo-4-oxo-1,2,3,4,5,8-
hexahydro-spirobenzo[b]thieno[2,3-d]-pyrimidine-
7(6H),10-cyclohexane (4c)
luted with H2O and extracted with CH2Cl2 (3 × 15 mL). The
combined organic layers were dried (Na2SO4), filtered and
concentrated. Column chromatography purification gave the
products 6a–c.
The product was obtained, following the general proce-
dure, as colorless crystals from methanol (0.63 g, 81%); m.
p. 189 – 190 ◦C. – 1H NMR (300 MHz, CDCl3): δ = 1.25
(t, 3H, J = 7.1 Hz, COOCH2CH3), 1.29 – 137 (m, 10H, H-
20,30,40,50,60), 1.57 (t, 2H, J = 6.2 Hz, H-6), 2.39 (s, 2H, H-
8), 2.78 (t, 2H, J = 6.2 Hz, H-5), 4.22 (q, 2H, J = 7.1 Hz,
COOCH2CH3), 5.17 (s, 2H, N-CH2), 11.95 (bs, 1H, NH).
3-(2-Ethoxy-2-oxoethyl)-2-[(1-(2,3,4,6-tetra-o-acetyl-β-d-
glucopyranosyl)-1H-1,2,3-triazol-4-yl)methyl]sulfanyl-4-
oxo-3,4,5,8-tetrahydro-spirobenzo[b]thieno[2,3-d]-
pyrimidine-7(6H),10-cyclohexane (6a)
The product was obtained, following the general pro-
cedure under stirring at r. t. for 16 h as colorless crystals
(0.73 g, 91%); m. p. 180 – 181 ◦C. – Rf = 0.34 (CH2Cl2-
CH3OH, 98:2). – 1H NMR (300 MHz, CDCl3): δ = 1.22
(t, 3H, J = 7.1 Hz, COOCH2CH3), 1.33 – 144 (m, 10H, H-
20,30,40,50,60), 1.62 (t, 2H, J = 6.4 Hz, H-6), 1.76 (s, 3H,
COCH3), 1.95 (s, 3H, COCH3), 1.98 (s, 3H, COCH3), 1.99
(s, 3H, COCH3), 2.52 (s, 2H, H-8), 2.88 (t, 2H, J = 6.1 Hz,
H-5), 3.90 – 4.21 (m, 5H, COOCH2CH3, C5H-CH2-OCO,
C5H-CH2-OCO), 4.47 – 4.53 (br, 2H, CH2-Ctriazole), 4.76
(s, 2H, N-CH2), 5.18 (m, 1H, C3H), 5.33 (m, 2H, C2H,
C4H ), 5.76 (d, 1H, J = 6.4 Hz, C1H-Ntriazole), 7.78 (s,
1H, CHar−triazole). – 13C NMR (75 MHz, CDCl3): δ = 14.1
(CH3), 20.1, 20.5, 20.6, 20.7 (4COCH3), 21.8 (C-30,50),
22.2 (C-5), 26.6 (C-40), 27.1 (CH2-C), 32.4 (C-6), 32.9
(Cq), 36.0 (C-20,60), 36.4 (C-8), 44.5 (N-CH2), 61.5 (C5H-
CH2-OCO), 62.0 (CH2, ester), 67.7 (C4H), 70.2 (C2H),
72.6 (C3H), 75.2 (C5H), 85.9 (C1H-Ntriazole), 118.6 (C-
4a), 121.6 (CHar−triazole), 130.5 (C-8a), 131.5 (C-4b), 142.2
(Cq−triazole), 154.6 (C-9a), 158.0 (C=O), 162.0 (C=O, es-
ter), 166.9 (C-2), 168.7, 169.4, 169.9, 170.5 (4COCH3).
– HRMS (ESI): m/z = 804.2420 (calcd. 804.2584 for
C36H46N5O12S2, [M+H]+).
–
13C NMR (75 MHz, CDCl3): δ = 14.2 (CH3), 21.8 (C-
30,50), 22.0 (C-5), 26.5 (C-40), 32.1 (C-6), 33.1 (Cq), 35.8,
35.9 (C-20,60), 36.1 (C-8), 47.3 (N-CH2), 61.9 (CH2, es-
ter), 116.5 (C-4b), 128.8 (C-4a), 131.2 (C-8a), 148.9 (C-9a),
154.4 (C=O), 154.9 (C=O, ester), 174.6 (C=S). – HRMS
(ESI): m/z = 393.1333 (calcd. 393.1307 for C19H25N2O3S2,
[M+H]+).
Synthesis of 3-(2-ethoxy-2-oxoethyl)-2-propargylsulfanyl-4-
oxo-3,4,5,8-tetrahydro-spiro-benzo[b]thieno[2,3-d]-
pyrimidine-7(6H),10-cyclohexane (5)
Propargyl bromide (1.10 g, 9 mmol) was added to a sus-
pension of compound 4c (1.18 g, 3 mmol) and iPr2NEt
(0.70 g, 6 mmol) in DMF (15 mL) and the resulting mix-
ture was stirred at room temperature for 6 h. The solution
was evaporated to dryness in vacuo. The residue was diluted
with water and then extracted with CH2Cl2 (3 × 30 mL).
The combined organic extracts were dried over anhydrous
Na2SO4, filtered and the solvents evaporated under reduced
pressure. The obtained product was purified by column chro-
matography. Yield: 0.91 g (71%); m. p. 112 – 113 ◦C. –
Rf = 0.65 (CH2Cl2, 100%). – 1H NMR (300 MHz, CDCl3):
δ = 1.24 (t, 3H, J = 7.1 Hz, COOCH2CH3), 1.31 – 140 (m,
10H, H-20,30,40,50,60), 1.60 (t, 2H, J = 6.2 Hz, H-6), 2.18 (bs,
1H, C-CH), 2.50 (s, 2H, H-8), 2.86 (t, 2H, J = 5.8 Hz, H-
5), 3.96 (d, 2H, J = 2.4 Hz, CH2-C), 4.20 (q, 2H, J = 7.1 Hz,
COOCH2CH3), 4.76 (s, 2H, N-CH2). – 13C NMR (75 MHz,
CDCl3): δ = 14.1 (CH3), 21.3, 21.8 (C-30,50), 22.2 (C-5),
26.6 (C-40), 32.5 (C-6), 32.9 (Cq), 36.0 (C-20,60), 36.3 (C-
8), 44.5 (N-CH2), 54.2 (CH2-C), 62.1 (CH2, ester), 72.2 (C-
CH), 77.7 (C-CH), 118.5 (C-4a), 130.3 (C-8a), 131.7 (C-
4b), 153.7 (C-9a), 157.9 (C=O), 162.0 (C=O, ester), 166.8
(C-2). – HRMS (ESI): m/z = 431.1476 (calcd. 431.1463 for
C22H27N2O3S2, [M+H]+).
3-(2-Ethoxy-2-oxoethyl)-2-[(1-(2,3,4,6-tetra-o-acetyl-β-d-
galactopyranosyl)-1H-1,2,3-triazol-4-yl)methyl]sulfanyl-4-
oxo-3,4,5,8-tetrahydro-spirobenzo[b]thieno[2,3-d]-
pyrimidine-7(6H),10-cyclohexane (6b)
The product was obtained, following the general pro-
cedure, under stirring at r. t. for 12 h as colorless crys-
tals (0.75 g, 94%); m. p. 92 – 93 ◦C. – Rf = 0.39 (CH2Cl2-
CH3OH, 98:2). – 1H NMR (300 MHz, CDCl3): δ = 1.23
(t, 3H, J = 7.1 Hz, COOCH2CH3), 1.33 – 144 (m, 10H, H-
20,30,40,50,60), 1.62 (t, 2H, J = 6.3 Hz, H-6), 1.78 (s, 3H,
COCH3), 1.94 (s, 3H, COCH3), 1.96 (s, 3H, COCH3), 2.13
(s, 3H, COCH3), 2.50 (s, 2H, H-8), 2.88 (t, 2H, J = 5.9 Hz,
H-5), 4.19 (m, 5H, COOCH2CH3, C5H-CH2-OCO, C5H-
CH2-OCO), 4.44 – 4.58 (m, 2H, CH2-Ctriazole), 4.76 (s, 2H,
Synthesis of 6a – c
The azido compound (1.0 mmol) was added to the alkyne N-CH2), 5.17 (dd, 1H, J1 = 3.3 Hz, J2 = 10.3 Hz, C3H),
substrate 5 (1.0 mmol) in CH3OH-H2O (1:1) (25 mL). Then 5.47 (m, 2H, C2H, C4H ), 5.73 (d, 1H, J = 9.2 Hz, C1H-
sodium ascorbate (0.4 mmol) and CuSO4·5H2O (0.2 mmol) Ntriazole), 7.79 (s, 1H, CHar−triazole). – 13C NMR (75 MHz,
were added. The mixture was stirred at room temperature CDCl3): δ = 14.1 (CH3), 20.2, 20.5, 20.6, 20.7 (4COCH3),
for the specified time. The mixture was concentrated, di- 21.8 (C-30,50), 22.2 (C-5), 26.6 (C-40), 27.2 (CH2-C),
Unauthenticated
Download Date | 3/17/17 3:20 PM